Ensuring High and Equitable COVID-19 Vaccine Uptake Among Patients With IBD.
Inflamm Bowel Dis
; 27(10): 1703-1705, 2021 Oct 18.
Article
in English
| MEDLINE | ID: covidwho-1740876
ABSTRACT
The recent emergency use authorization of a third COVID-19 vaccine means that most patients with inflammatory bowel disease (IBD) will soon be eligible to be vaccinated. Gastroenterology clinicians should be prepared to address patients' concerns regarding safety and efficacy of vaccines. They should also strongly recommend that all their patients be vaccinated with a COVID-19 vaccine. Additionally, they should be prepared to educate patients about logistics that will result in successful vaccination completion. All these measures will be crucial to ensure high uptake among their patients with IBD.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Inflammatory Bowel Diseases
/
Vaccination
/
Gastroenterologists
/
COVID-19 Vaccines
/
COVID-19
Type of study:
Observational study
/
Prognostic study
/
Qualitative research
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Inflamm Bowel Dis
Journal subject:
Gastroenterology
Year:
2021
Document Type:
Article
Affiliation country:
Ibd
Similar
MEDLINE
...
LILACS
LIS